-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.
-
Summary
-
BIO-TECHNE Corp quarterly Deferred Income Tax Assets, Net history and change rate for Q2 2025.
- BIO-TECHNE Corp Deferred Income Tax Assets, Net for the quarter ending June 30, 2025 was $10.3M.